High frequency oscillatory ventilation combined with surfactant in treatment of preterm infants with respiratory distress syndrome: report of 100 cases
|更新时间:2026-01-09
|
High frequency oscillatory ventilation combined with surfactant in treatment of preterm infants with respiratory distress syndrome: report of 100 cases
Journal of Army Medical UniversityVol. 36, Issue 19, Pages: 2034-2036(2014)
Wang Li,Zhao Jinning,Hu Zhangxue,Tang Shifang,Ma Juan,Shi Yuan.High frequency oscillatory ventilation combined with surfactant in treatment of preterm infants with respiratory distress syndrome: report of 100 cases[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(19):2034-2036.
Wang Li,Zhao Jinning,Hu Zhangxue,Tang Shifang,Ma Juan,Shi Yuan.High frequency oscillatory ventilation combined with surfactant in treatment of preterm infants with respiratory distress syndrome: report of 100 cases[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(19):2034-2036.DOI:
High frequency oscillatory ventilation combined with surfactant in treatment of preterm infants with respiratory distress syndrome: report of 100 cases
Objective To determine the therapeutic effects of pulmonary surfactant (PS) combined with high frequency oscillatory ventilation (HFOV) or conventional mechanical ventilation (CMV) in preterm infants with respiratory distress syndrome (RDS). Methods One hundred preterm RDS infants within 12 h after birth admitted in our department from August 2012 to December 2012 were randomly divided into 2 groups
HFOV+PS group (n=48) and CMV+PS group (n=52). Their clinical symptoms and the results of blood gas before and after treatment
mechanical ventilation time
hospitalization time
cure rate and the incidences of complications were compared between the 2 groups. Results In HFOV+PS group
both clinical symptoms and blood gas got better (P0.05)
while
hospitalization time and mechanical ventilation time were obviously shorter than CMV+PS group (P0.05). What’s more
cure rate was significant higher in HFOV+PS group than CMV+PS group (P0.05). But the incidences of complications had no statistically significance between the 2 groups (P0.05). Conclusion HFOV+PS shows remarkable curative effect in treatment of RDS
and it has important significance in reducing premature mortality and improving cure rate at the same time.
Efficacy of non-invasive high frequency oscillatory ventilation as post-extubation respiratory support in preterm neonates: a randomized controlled trial
Difference of multi-center controlled clinical efficacy in treatment of neonatal respiratory distress syndrome with different initial doses of pulmonary surfactant
Timing for initial therapy of pulmonary surfactant to reduce pulmonary hemorrhage in neonatal respiratory distress syndrome: a multi-center retrospective study
Expression and polymorphism of surfactant protein B gene +1 580 in neonatal respiratory distress syndrome